• The study demonstrated that circulating GCC mRNA serves as a dependable indicator for predicting metastasis and as a prognostic marker in patients with early-stage CRC. This underscores its potential to offer valuable guidance for initiating clinical interventions before tumor dissemination occurs. The gene discussed is GUCY2C; the disease is colorectal carcinoma.